Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
| Industry | Market Weight | YTD Return | |
|---|---|---|---|
| All Industries | 100.00% | 2.00% | |
| Drug Manufacturers - General | 32.96% | -1.45% | |
| Medical Devices | 13.18% | 2.90% | |
| Healthcare Plans | 12.84% | 7.54% | |
| Diagnostics & Research | 11.30% | 3.95% | |
| Biotechnology | 10.81% | -0.56% | |
| Medical Instruments & Supplies | 8.25% | 4.87% | |
| Medical Care Facilities | 2.91% | 3.21% | |
| Drug Manufacturers - Specialty & Generic | 2.73% | 3.70% | |
| Medical Distribution | 2.55% | 4.01% | |
| Health Information Services | 2.31% | 4.47% | |
| Pharmaceutical Retailers | 0.17% | 32.62% | |
Note: Percentage % data on heatmap indicates Day Return
All Industries
--
<= -3
-2
-1
0
1
2
>= 3
Largest Companies in This Sector
View MoreName | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
|---|---|---|---|---|---|---|---|
| | 999.43 | 10.59% | | | | Buy | |
| | 625.10 | 7.89% | | | | Buy | |
| | 175.98 | 5.50% | | | | Buy | |
| | 208.90 | 4.77% | | | | Buy | |
| | 133.43 | 3.99% | | | | Buy | |
| | 657.43 | 3.33% | | | | Buy | |
| | 539.24 | 3.26% | | | | Buy | |
| | 130.24 | 3.04% | | | | Buy | |
| | 288.34 | 2.71% | | | | Buy | |
| | 32.62 | 2.34% | | | | Buy |
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| | 36.396B | 0.09% | | |
| | 18.975B | 0.10% | | |
| | 6.463B | 0.45% | | |
| | 6.369B | 0.35% | | |
| | 4.4B | 0.40% | |
Mutual Fund Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| | 40.511B | 0.30% | | |
| | 40.511B | 0.30% | | |
| | 18.975B | 0.10% | | |
| | 13.014B | 0.80% | | |
| | 13.014B | 0.80% | |
Healthcare Research
View MoreDiscover the Latest Analyst and Technical Research for This Sector
Analyst Report: Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
RatingPrice TargetPortfolio Selector for January, 2025
The Portfolio Selector features the Argus Focus List, a group of 30 "best idea" stocks generated and regularly updated by Argus' analysts and investment policy committee. It also includes the director of research’s monthly investment strategy column, stock recommendations and sector picks, economic forecasts, and an asset allocation model. This month, the Focus List additions are Illumina Inc (ILMN); United Airlines Holdings Inc (UAL); Toll Brothers Inc. (TOL); Morgan Stanley (MS) and the Focus List deletions are AECOM (ACM); Dicks Sporting Goods, Inc. (DKS); Goldman Sachs Group, Inc. (GS); Merck & Co Inc (MRK).
Daily – Vickers Top Insider Picks for 01/15/2025
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Buyers & Sellers for 01/15/2025
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
